Novo Nordisk Tokenized Stock (Reality) RNVO
RNVO
38.72
$
0.00 %
Change 24h
Market Cap
$ 333,158
Volume 24h
$ 20,600
Circulating Supply
8604
Total Supply
8604
RNVO
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.